Structural insights into a potent antimalarial drug candidate's interaction with the malaria parasite Plasmodium falciparum have paved the way for drug-resistant malaria therapies, according to a new study by researchers ...
Jan 18, 2024
0
7
Strongyloidiasis—a poorly understood parasitic worm disease common in remote Australian communities and some returned travelers, refugees or asylum seekers—is finally gaining attention in the national research arena.
Jan 12, 2024
0
0
Drug-resistant babesiosis may respond to a novel combination therapy, researchers say. The treatment, which involves the antimalarial drug tafenoquine and the anti-fungal/anti-parasite drug atovaquone, may also provide immunity ...
Jan 8, 2024
0
0
For the first time in 20 years, locally transmitted cases of malaria have been reported in the U.S.
Dec 20, 2023
0
0
The world's first medicine formulated to treat a damaging tropical parasite infection in preschool children received the green light Friday from Europe's drug agency.
Dec 15, 2023
0
0
Researchers at The Park Center for Mental Health, Australia, have added to the growing body of evidence that cat ownership is a major risk factor for schizophrenia and quantified the risk at more than double.
Researchers who have studied malaria for decades, hoping to find a cure, long thought they'd identified a type of blood that seemed to defend against the disease.
Dec 6, 2023
0
12
COVID-19 cast a glaring spotlight on the devastating impact that infectious diseases can have on human health and society. At the height of the global pandemic, most of the world came to a standstill, and millions of lives ...
Dec 5, 2023
0
0
For the first time, scientists have begun to figure out why the disfiguring skin lesions caused by cutaneous leishmaniasis don't hurt.
Nov 30, 2023
0
35
Similar to a burglar breaking a window to get into a house, Indiana University researchers have discovered a previously unknown process by which pathogens enter a cell with physical force, breaching the body's immune defenses ...
Nov 30, 2023
0
44
